Alaska Permanent Fund Corp Exelixis, Inc. Transaction History
Alaska Permanent Fund Corp
- $6.4 Billion
- Q2 2024
A detailed history of Alaska Permanent Fund Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Alaska Permanent Fund Corp holds 54,135 shares of EXEL stock, worth $1.43 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
54,135
Previous 53,239
1.68%
Holding current value
$1.43 Million
Previous $1.26 Million
3.72%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
240MCall Options Held
2.04MPut Options Held
1.29M-
Black Rock Inc. New York, NY33.5MShares$885 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$783 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$716 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$400 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$333 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $8.5B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...